Suppr超能文献

长期低剂量的Δ9-四氢大麻酚(THC)给予感染猴免疫缺陷病毒(SIV)的恒河猴可刺激释放具有生物活性的血液细胞外囊泡(EVs),诱导不同的结构适应和信号转导。

Long-Term Low-Dose Delta-9-Tetrahydrocannbinol (THC) Administration to Simian Immunodeficiency Virus (SIV) Infected Rhesus Macaques Stimulates the Release of Bioactive Blood Extracellular Vesicles (EVs) that Induce Divergent Structural Adaptations and Signaling Cues.

机构信息

Department of Pharmacology, Stony Brook University Renaissance School of Medicine, Stony Brook, NY 11794-8651, USA.

Host Pathogen Interaction, Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78227-5302, USA.

出版信息

Cells. 2020 Oct 6;9(10):2243. doi: 10.3390/cells9102243.

Abstract

Blood extracellular vesicles (BEVs) carry bioactive cargo (proteins, genetic materials, lipids, licit, and illicit drugs) that regulate diverse functions in target cells. The cannabinoid drug delta-9-tetrahydrocannabinol (THC) is FDA approved for the treatment of anorexia and weight loss in people living with HIV. However, the effect of THC on BEV characteristics in the setting of HIV/SIV infection needs to be determined. Here, we used the SIV-infected rhesus macaque model of AIDS to evaluate the longitudinal effects of THC (THC/SIV) or vehicle (VEH/SIV) treatment in HIV/SIV infection on the properties of BEVs. While BEV concentrations increased longitudinally (pre-SIV (0), 30, and 150 days post-SIV infection (DPI)) in VEH/SIV macaques, the opposite trend was observed with THC/SIV macaques. SIV infection altered BEV membrane properties and cargo composition late in infection, since i) the electrostatic surface properties (zeta potential, ζ potential) showed that RM BEVs carried negative surface charge, but at 150 DPI, SIV infection significantly changed BEV ζ potential; ii) BEVs from the VEH/SIV group altered tetraspanin CD9 and CD81 levels compared to the THC/SIV group. Furthermore, VEH/SIV and THC/SIV BEVs mediated divergent changes in monocyte gene expression, morphometrics, signaling, and function. These include altered tetraspanin and integrin β1 expression; altered levels and distribution of polymerized actin, FAK/pY397 FAK, pERK1/2, cleaved caspase 3, proapoptotic Bid and truncated tBid; and altered adhesion of monocytes to collagen I. These data indicate that HIV/SIV infection and THC treatment result in the release of bioactive BEVs with potential to induce distinct structural adaptations and signaling cues to instruct divergent cellular responses to infection.

摘要

血液细胞外囊泡(BEVs)携带生物活性货物(蛋白质、遗传物质、脂质、合法和非法药物),调节靶细胞的多种功能。大麻素药物Δ-9-四氢大麻酚(THC)已获得美国食品和药物管理局(FDA)批准,用于治疗艾滋病毒感染者的厌食和体重减轻。然而,在 HIV/SIV 感染的情况下,THC 对 BEV 特征的影响仍需确定。在这里,我们使用 SIV 感染的恒河猴艾滋病模型来评估 HIV/SIV 感染中 THC(THC/SIV)或载体(VEH/SIV)治疗的纵向影响对 BEV 特性的影响。虽然在 VEH/SIV 猕猴中,BEV 浓度随时间增加(感染前(0)、感染后 30 和 150 天(DPI)),但在 THC/SIV 猕猴中则观察到相反的趋势。SIV 感染改变了 BEV 膜特性和货物组成,因为 i)静电表面特性(zeta 电位,ζ 电位)表明 RM BEVs 带有负表面电荷,但在 150 DPI 时,SIV 感染显著改变了 BEV ζ 电位;ii)与 THC/SIV 组相比,VEH/SIV 组的 BEVs 改变了四跨膜蛋白 CD9 和 CD81 的水平。此外,VEH/SIV 和 THC/SIV BEVs 介导了单核细胞基因表达、形态、信号和功能的不同变化。这些变化包括改变了四跨膜蛋白和整合素β1 的表达;改变了聚合肌动蛋白、FAK/pY397 FAK、pERK1/2、cleaved caspase 3、促凋亡 Bid 和截断 tBid 的水平和分布;以及改变了单核细胞与胶原蛋白 I 的黏附。这些数据表明,HIV/SIV 感染和 THC 治疗导致释放具有潜在生物活性的 BEVs,这些 BEVs可能诱导不同的结构适应和信号提示,以指导对感染的不同细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae5d/7599525/84f244e72c17/cells-09-02243-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验